Skip to main content

Table. 1 Baseline and Characteristics

From: Bilirubin adsorption versus plasma exchange for hyperbilirubinemia in patients after cardiac surgery: a retrospective study

Variable Bilirubin adsorption (n = 14) Plasma exchange (n = 42) P value
Age (year) 62.2 ± 14.9 67.2 ± 8.5 0.125
Gender (male, %) 10, 71.4% 31, 73.8% 0.862
Weight (kg) 64.4 ± 10.4 62.4 ± 8.6 0.477
NYHA class (n, %)    0.329
 I 0 0  
 II 0 1, 2.3%  
 III 6, 42.8% 23, 54.8%  
 IV 8, 57.2% 18, 42.9%  
EuroSCORE II 30.5 ± 17.5 20.9 ± 7.6 0.006
Previous Medical History (n,%)    
 Acute Myocardial infarction 5, 35.7% 9, 21.4% 0.285
 Diabetes Mellitus 7, 50.0% 11, 26.2% 0.099
 Chronic Renal Failure 0 0
 Hypertension 11, 78.6% 24, 26.2% 0.151
 Liver Disease 0 0
 Smoking 5, 35.7% 11, 26.2% 0.495
Type of cardiac operation (n,%)    0.890
 CABG 1, 7.1% 4, 9.5%  
 Valvular surgery 5, 35.7% 14, 33.3%  
 CABG + Valvular surgery 4, 28.6% 13, 31.0%  
 Aortic surgery 4, 28.6% 11, 26.2%  
CPB time 251.1 ± 79.7 218.1 ± 80.4 0.20
ACC time 187.8 ± 65.1 157.8 ± 58.2 0.12
Pre-operation liver function    
 ALT 29.0 (13.4–58.7) 25.0.3 (17–51.3) 0.813
 AST 34.1 (20.2–109.4) 30.5 (17.9–37.6) 0.348
 GGT 102.8 ± 70.9 74.1 ± 38.2 0.225
 TBil 23.3 ± 15.1 18.3 ± 9.9 0.157
 DBil 10.3 ± 7.3 9.6 ± 6.4 0.715
 LDH 230.9 ± 116.5 183.4 ± 83.4 0.176
 Serum albumin 38.7 ± 4.8 38.8 ± 3.5 0.906
 Pre-operation Serum Creatinine 115.9 ± 77.5 95.4 ± 53.8 0.276
  1. Mean ± SD: Median (Interquartile range), CABG: Coronary artery bypass grafting, CPB: Cardiopulmonary bypass, CPB: Cardiopulmonary bypass, AST: Aspartate aminotransferase, CPB: Cardiopulmonary bypass, ALT: Alanine aminotransferase, GGT: Gamma-glutamyl transpeptidase, TBil: Total bilirubin, DBil: Direct bilirubin, LDH: Lactate dehydrogenase, NYHA: New York Heart Association